768729128	768729128	CD	B-NP	O
|	|	NN	I-NP	O
TMC	TMC	NN	I-NP	O
|	|	NN	I-NP	O
84870302	84870302	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4841712	4841712	CD	B-NP	O
|	|	CC	I-NP	O
6/4/2005	6/4/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
GRAFT	GRAFT	NNP	I-NP	I-protein
VS	VS	NNP	I-NP	O
HOST	HOST	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
,	,	,	O	O
S/P	S/P	NNP	B-NP	O
BONE	BONE	NNP	I-NP	O
MARROW	MARROW	NNP	I-NP	O
TRANSPLANT	TRANSPLANT	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/1/2005	4/1/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/15/2005	10/15/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BABILONIA	BABILONIA	NNP	B-NP	O
,	,	,	O	O
HARRISON	HARRISON	NNP	B-NP	O
LENARD	LENARD	NNP	I-NP	O
HILARIO	HILARIO	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Graft	Graft	NN	B-NP	O
versus	versus	IN	B-PP	O
host	host	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
in	in	IN	B-PP	O
1/25	1/25	CD	B-NP	O
developed	develop	VBD	B-VP	O
right	right	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
stage	stage	NN	B-NP	O
III	III	CD	I-NP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
included	include	VBD	B-VP	O
lumpectomy	lumpectomy	NN	B-NP	O
and	and	CC	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
pancytopenia	pancytopenia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
10/4	10/4	CD	B-NP	O
with	with	IN	B-PP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
aspirate	aspirate	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
cytogenetic	cytogenetic	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
with	with	IN	B-PP	O
findings	finding	NNS	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
myelodysplastic	myelodysplastic	JJ	B-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
8/14	8/14	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
nonmyeloblative	nonmyeloblative	JJ	I-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
transplant	transplant	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
match	match	NN	I-NP	O
unrelated	unrelated	JJ	I-NP	O
donor	donor	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
10/18	10/18	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
lymphocyte	lymphocyte	NN	B-NP	O
infusion	infusion	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
5/8	5/8	CD	B-NP	O
,	,	,	O	O
chimerism	chimerism	NN	B-NP	O
study	study	NN	I-NP	O
showed	show	VBD	B-VP	O
58	58	CD	B-NP	O
%	%	NN	I-NP	O
donor	donor	NN	I-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
chimerism	chimerism	NN	I-NP	O
on	on	IN	B-PP	O
8/23/05	8/23/05	CD	B-NP	O
showed	show	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
chimerism	chimerism	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
had	have	VBD	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
watery	watery	NN	B-NP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
sick	sick	JJ	B-NP	O
contacts	contact	NNS	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
GI	GI	NN	B-NP	O
biopsy	biopsy	NN	I-NP	O
in	in	IN	B-PP	O
middle	middle	NN	B-NP	O
of	of	IN	B-PP	O
5/24	5/24	CD	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
focal	focal	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
GVHD	GVHD	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
prescription	prescription	NN	B-NP	O
for	for	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	O	O
complete	complete	JJ	B-ADJP	O
or	or	CC	O	O
fill	fill	VB	B-VP	O
the	the	DT	B-NP	O
prescription	prescription	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
skin	skin	NN	I-NP	O
rash	rash	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
graft	graft	NN	B-NP	O
versus	versus	CC	I-NP	O
host	host	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Includes	Include	VBZ	B-VP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
1/25	1/25	CD	B-NP	O
,	,	,	O	O
myelodysplastic	myelodysplastic	JJ	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
complicated	complicate	VBN	B-NP	O
migraine	migraine	NN	I-NP	O
headache	headache	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
aortic	aortic	JJ	B-NP	O
valvular	valvular	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
no	no	DT	B-NP	O
allergies	allergy	NNS	I-NP	O
to	to	TO	B-PP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
divorced	divorce	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
son	son	NN	I-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
or	or	CC	I-NP	O
illicit	illicit	JJ	I-NP	O
drug	drug	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
FINDINGS	FINDINGS	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
dry	dry	JJ	B-NP	O
maculopapular	maculopapular	JJ	I-NP	O
rash	rash	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
chest	chest	NN	I-NP	O
and	and	CC	I-NP	O
face	face	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
abdomen	abdoman	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
upper	upper	JJ	B-NP	O
thighs	thigh	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
slightly	slightly	RB	B-ADJP	O
erythematous	erythematous	JJ	I-ADJP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
dry	dry	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
percussion	percussion	NN	B-NP	O
and	and	CC	I-NP	O
auscultation	auscultation	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBD	B-VP	O
best	good	JJS	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
appreciated	appreciate	VBN	B-VP	O
on	on	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
large	large	JJ	B-NP	O
external	external	JJ	I-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Oncology	Oncology	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
MDS	MDS	NN	B-NP	O
,	,	,	O	O
11	11	CD	B-NP	O
months	month	NNS	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
nonmyeloablative	nonmyeloablative	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
slow	slow	JJ	I-ADJP	O
to	to	TO	B-PP	O
engraft	engraft	NN	B-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
donor	donor	NN	B-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
infusion	infusion	NN	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
chimerism	chimerism	NN	I-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
8/23/05	8/23/05	CD	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
donor	donor	NN	I-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
stage	stage	NN	B-NP	O
III	III	CD	I-NP	O
skin	skin	NN	I-NP	O
GVH	GVH	NN	I-NP	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
biopsy	biopsy	NN	B-NP	O
on	on	IN	B-PP	O
6/15/05	6/15/05	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
8/5/05	8/5/05	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
prednisone	prednisone	NN	B-NP	O
on	on	IN	B-PP	O
6/11/05	6/11/05	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	I-NP	O
Elidel	Elidel	NNP	I-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
5/22/05	5/22/05	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
even	even	RB	B-NP	O
more	more	JJR	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
GVH	GVH	NN	I-NP	O
since	since	IN	B-PP	O
initiating	initiate	VBG	B-VP	O
rapamycin	rapamycin	NN	B-NP	O
on	on	IN	B-PP	O
8/6	8/6	CD	B-NP	O
Gut	Gut	NNP	I-NP	O
GVH/diarrhea	GVH/diarrhea	NNP	I-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
biopsy	biopsy	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/05	5/10/05	CD	B-NP	O
showed	show	VBD	B-VP	O
grade	grade	NN	B-NP	O
II	II	CD	I-NP	O
graft	graft	NN	I-NP	O
versus	versus	IN	B-PP	O
host	host	NN	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
transverse	transverse	JJ	I-NP	O
colon	colon	NN	I-NP	O
,	,	,	O	O
grade	grade	NN	B-NP	O
I	I	CD	I-NP	O
graft	graft	NN	I-NP	O
versus	versus	CC	I-NP	O
host	host	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
viral	viral	JJ	I-NP	O
cytopathic	cytopathic	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
stools	stool	NNS	B-NP	O
with	with	IN	B-PP	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
,	,	,	O	O
marginal	marginal	JJ	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
rapamycin	rapamycin	NN	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
improvement	improvement	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
three	three	CD	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
ONTAK	ONTAK	NN	B-NP	B-protein
.	.	.	O	O

ONTAK	ONTAK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
on	on	IN	B-PP	O
6/17/05	6/17/05	CD	B-NP	O
,	,	,	I-NP	O
9/6/05	9/6/05	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
10/22/05	10/22/05	CD	B-NP	O
without	without	IN	B-PP	O
adverse	adverse	JJ	B-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
premedicated	premedicate	VBN	I-VP	O
with	with	IN	B-PP	O
Pepcid	Pepcid	NNP	B-NP	O
,	,	,	O	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
Benadryl	Benadryl	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Tylenol	Tylenol	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
only	only	JJ	I-NP	O
side	side	NN	I-NP	O
effect	effect	NN	I-NP	O
is	be	VBZ	B-VP	O
marked	marked	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	B-protein
upper	upper	JJ	I-NP	I-protein
extremity	extremity	NN	I-NP	I-protein
edema	edema	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
see	see	VBP	B-VP	O
cardiovascular	cardiovascular	JJ	B-NP	O
section	section	NN	I-NP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
details	detail	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Solu-Medrol	Solu-Medrol	NN	B-NP	O
IV	IV	CD	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
2	2	CD	B-NP	O
mg/kg/day	mg/kg/day	NN	I-NP	O
,	,	,	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
8/5/05	8/5/05	CD	B-NP	O
,	,	,	O	O
changed	change	VBD	B-VP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
mg/kg	mg/kg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	JJ	B-NP	O
oral	oral	JJ	I-NP	O
steroids	steroid	NNS	I-NP	O
on	on	IN	B-PP	O
6/13/05	6/13/05	CD	B-NP	O
.	.	.	O	O

Began	Began	NNP	B-NP	O
tapering	taper	VBG	B-VP	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
at	at	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
on	on	IN	B-PP	O
11/18/05	11/18/05	CD	B-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
8/20/05	8/20/05	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
on	on	IN	B-PP	O
10/24/05	10/24/05	CD	B-NP	O
.	.	.	O	O

Rapamycin	Rapamycin	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
,	,	,	O	O
goal	goal	JJ	B-NP	O
level	level	NN	I-NP	O
between	between	IN	B-PP	O
3	3	CD	B-NP	O
and	and	CC	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
since	since	IN	B-PP	O
initiating	initiate	VBG	B-VP	O
therapy	therapy	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
on	on	IN	B-PP	O
GVH	GVH	NN	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
coordinating	coordinate	VBG	B-VP	O
with	with	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
and	and	CC	I-NP	O
kitchen	kitchen	NN	I-NP	O
for	for	IN	B-PP	O
correct	correct	JJ	B-NP	O
menu	menu	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
lactose-restricted	lactose-restricted	JJ	B-NP	O
diet	diet	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
helped	help	VBN	I-VP	O
the	the	DT	B-NP	O
stool	stool	NN	I-NP	O
volume	volume	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
for	for	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
26	26	CD	B-NP	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
intermittent	intermittent	JJ	B-NP	O
bright	bright	JJ	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
and	and	CC	O	O
clots	clot	NNS	B-NP	O
in	in	IN	B-PP	O
stool	stool	NN	B-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
on	on	IN	B-PP	O
10/2/05	10/2/05	CD	B-NP	O
and	and	CC	I-NP	O
8/25/05	8/25/05	CD	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
large	large	JJ	B-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
colonoscopy	colonoscopy	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
prophylactic	prophylactic	JJ	B-NP	O
medication	medication	NN	I-NP	O
of	of	IN	B-PP	O
Mepron	Mepron	NN	B-NP	O
and	and	CC	I-NP	O
acyclovir	acyclovir	NN	I-NP	O
.	.	.	O	O

Cytomegalovirus	Cytomegalovirus	NN	B-NP	O
viral	viral	JJ	I-NP	O
load	load	NN	I-NP	O
on	on	IN	B-PP	O
2/7/05	2/7/05	CD	B-NP	O
,	,	,	I-NP	O
8/5/05	8/5/05	CD	I-NP	O
,	,	,	I-NP	O
5/10/05	5/10/05	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
10/10/05	10/10/05	CD	B-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
negative	negative	JJ	I-NP	O
.	.	.	O	O

CMV	CMV	NN	B-NP	O
viral	viral	JJ	I-NP	O
load	load	NN	I-NP	O
on	on	IN	B-PP	O
9/6/05	9/6/05	CD	B-NP	O
was	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
acyclovir	acyclovir	NN	B-NP	O
and	and	CC	I-NP	O
Mepron	Mepron	NN	I-NP	O
once	once	RB	B-VP	O
transferred	transfer	VBN	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
get	get	VB	I-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
left	leave	VBN	I-VP	O
upper	upper	JJ	B-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
markedly	markedly	RB	B-VP	O
worsened	worsen	VBD	I-VP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
tacrolimus	tacrolimus	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
cause	cause	VB	I-VP	O
capillary	capillary	JJ	B-NP	O
leak	leak	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
on	on	IN	B-PP	O
11/28/05	11/28/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
.	.	.	O	O

Etiology	Etiology	NN	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
lymphedema	lymphedema	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
axillary	axillary	JJ	B-NP	O
resection	resection	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
capillary	capillary	JJ	B-NP	O
leak	leak	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
ONTAK	ONTAK	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
borderline	borderline	JJ	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
minimal	minimal	JJ	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
when	when	WRB	B-ADVP	O
speaking	speak	VBG	B-VP	O
on	on	IN	B-PP	O
11/16/05	11/16/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
without	without	IN	B-PP	O
further	further	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
10/6/05	10/6/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
small	small	JJ	B-NP	O
left	left	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
without	without	IN	B-PP	O
other	other	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	NNP	B-NP	O
:	:	:	O	O
Mouth	Mouth	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
dry	dry	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADVP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
graft	graft	NN	B-NP	O
versus	versus	CC	I-NP	O
host	host	NN	I-NP	O
disease	disease	NN	I-NP	O
using	use	VBG	B-VP	O
ice	ice	NN	B-NP	O
chips	chip	NNS	I-NP	O
and	and	CC	O	O
mouth	mouth	NN	B-NP	O
coat	coat	NN	I-NP	O
is	be	VBZ	B-VP	O
helpful	helpful	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
this	this	DT	B-NP	O
throughout	throughout	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Gut	Gut	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
loose	loose	JJ	I-NP	O
stools	stool	NNS	I-NP	O
improved	improve	VBD	B-VP	O
-LRB-	-LRB-	HYPH	O	B-protein
see	see	VB	B-VP	O
oncology	oncology	NN	B-NP	B-protein
section	section	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Clostridium	Clostridium	NN	B-NP	O
difficile	difficile	JJ	I-NP	O
testing	testing	NN	I-NP	O
sent	send	VBN	B-VP	O
on	on	IN	B-PP	O
8/26/05	8/26/05	CD	B-NP	O
and	and	CC	I-NP	O
3/5/05	3/5/05	CD	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
bright	bright	JJ	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
external	external	JJ	B-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
stated	state	VBN	B-VP	O
above	above	RB	B-ADVP	O
in	in	IN	B-PP	O
GI	GI	NN	B-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

Colonoscopy	Colonoscopy	NN	B-NP	O
on	on	IN	B-PP	O
5/10/05	5/10/05	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
stage	stage	NN	B-NP	O
II	II	CD	I-NP	O
GVHD	GVHD	NN	I-NP	O
on	on	IN	B-PP	O
biopsy	biopsy	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
gross	gross	JJ	I-NP	O
visual	visual	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
bleed	bleed	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
now	now	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
7/16/05	7/16/05	CD	B-NP	O
with	with	IN	B-PP	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
large	large	JJ	B-NP	O
hemorrhagic	hemorrhagic	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
intubating	intubate	VBG	B-VP	O
internal	internal	JJ	B-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
biopsies	biopsy	NNS	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
graft	graft	NN	B-NP	O
versus	versus	CC	I-NP	O
host	host	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
3/5/05	3/5/05	CD	B-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
transaminitis	transaminitis	NN	I-NP	O
on	on	IN	B-PP	O
8/29/05	8/29/05	CD	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
ONTAK	ONTAK	NN	B-NP	B-protein
would	would	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
transient	transient	JJ	B-NP	O
LFT	LFT	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
when	when	WRB	B-ADVP	O
first	first	RB	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
since	since	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
since	since	IN	B-PP	O
discontinuing	discontinue	VBG	B-VP	O
Bactrim	Bactrim	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
remained	remain	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Rectum	Rectum	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
Anusol	Anusol	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
hemorrhoids	hemorrhoid	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
immunosuppression	immunosuppression	NN	B-NP	O
and	and	CC	I-NP	O
infection	infection	NN	I-NP	O
risk	risk	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
repeated	repeat	VBN	B-VP	O
increasing	increase	VBG	B-NP	O
creatinine	creatinine	NN	I-NP	O
to	to	TO	B-PP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
maintained	maintain	VBD	B-VP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
to	to	TO	B-PP	O
1.2	1.2	CD	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
marked	mark	VBN	I-VP	O
peripheral	peripheral	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Diureses	Diures	NNS	B-NP	O
worked	work	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
18	18	CD	I-NP	O
kg	kg	NN	I-NP	O
above	above	IN	B-PP	O
admit	admit	NN	B-NP	O
weight	weight	NN	I-NP	O
and	and	CC	O	O
now	now	RB	B-ADVP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
only	only	RB	B-NP	O
3	3	CD	I-NP	O
kg	kg	NN	I-NP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
admit	admit	NN	I-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
10/24/05	10/24/05	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
combination	combination	NN	B-NP	O
to	to	TO	B-PP	O
venous	venous	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
low	low	JJ	B-NP	O
albumin	albumin	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
ONTAK	ONTAK	NN	B-NP	B-protein
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
albumin	albumin	NN	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
needed	need	VBN	B-VP	O
now	now	RB	B-ADVP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
that	that	WDT	B-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
pursuing	pursue	VBG	I-VP	O
ONTAK	ONTAK	NN	B-NP	B-protein
therapy	therapy	NN	I-NP	O
until	until	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
attending	attend	VBG	B-VP	O
decides	decide	NNS	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
I/O	I/O	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
hemodynamics	hemodynamic	NNS	I-NP	O
closely	closely	RB	B-ADVP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dehydrated	dehydrate	VBN	I-VP	O
.	.	.	O	O

Encouraged	Encouraged	JJ	B-NP	O
ambulation	ambulation	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
elevation	elevation	NN	B-NP	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
using	use	VBG	I-VP	O
Ace	Ace	NNP	B-NP	O
bandage	bandage	NN	I-NP	O
like	like	IN	B-PP	O
wraps	wrap	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
electrolytes	electrolyte	NNS	B-NP	O
monitored	monitor	VBN	B-VP	O
and	and	CC	I-VP	O
repleaded	repleade	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
following	follow	VBG	I-VP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
134	134	CD	B-NP	O
and	and	CC	I-NP	O
163	163	CD	I-NP	O
,	,	,	O	O
improved	improve	VBD	B-VP	O
since	since	IN	B-SBAR	O
steroids	steroid	NNS	B-NP	O
taper	taper	NN	I-NP	O
initiated	initiate	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
likely	likely	RB	B-ADVP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Dermatology	Dermatology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
skin	skin	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
GVH	GVH	NN	B-NP	B-protein
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
body	body	NN	I-NP	O
surface	surface	NN	I-NP	O
area	area	NN	I-NP	O
involved	involve	VBN	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
significantly	significantly	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
less	less	JJR	B-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
darkening	darken	VBG	B-VP	O
rash	rash	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
decreased	decrease	VBN	B-NP	O
distribution	distribution	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
GVH	GVH	NN	B-NP	O
medication	medication	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
stated	state	VBN	B-VP	O
in	in	IN	B-PP	O
Oncology	Oncology	NNP	B-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
macerated	macerate	VBN	B-NP	O
areas	area	NNS	I-NP	O
under	under	IN	B-PP	O
both	both	CC	O	O
breast	breast	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
miconazole	miconazole	NN	B-NP	O
powder	powder	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Access	Access	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
double	double	JJ	B-NP	O
lumen	lumen	NN	I-NP	O
Hickman	Hickman	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
erythematous	erythematous	JJ	B-NP	O
surrounding	surround	VBG	I-NP	O
exit	exit	NN	I-NP	O
site	site	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cuff	cuff	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
exposed	expose	VBN	I-VP	O
for	for	IN	B-PP	O
months	month	NNS	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	B-NP	O
not	not	RB	I-NP	O
tender	tender	NN	B-NP	O
,	,	,	O	O
outpatient	outpatient	NN	B-NP	O
attending	attend	VBG	B-VP	O
requested	request	VBN	I-VP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
it	it	PRP	B-NP	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
accepted	accept	VBN	B-VP	O
at	at	IN	B-PP	O
Dwan	Dwan	NNP	B-NP	O
Uoswe	Uoswe	NNP	I-NP	O
Chehamp	Chehamp	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Center	Center	NNP	I-NP	O
We	We	PRP	B-NP	O
had	have	VBD	B-VP	O
family	family	NN	B-NP	O
meeting	meeting	NN	I-NP	O
on	on	IN	B-PP	O
8/20/05	8/20/05	CD	B-NP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
siblings	sibling	NNS	I-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
son	son	NN	I-NP	O
agreed	agree	VBD	B-VP	O
on	on	IN	B-PP	O
once	once	RB	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
need	need	VBP	B-VP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
support	support	NN	I-NP	O
,	,	,	O	O
medication	medication	NN	B-NP	O
compliance	compliance	NN	I-NP	O
,	,	,	O	O
Mitchel	Mitchel	NNP	B-NP	O
Hursey	Hursey	NNP	I-NP	O
,	,	,	O	O
social	social	JJ	B-NP	O
worker	worker	NN	I-NP	O
from	from	IN	B-PP	O
Tinmasca	Tinmasca	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
is	be	VBZ	B-VP	O
following	follow	VBG	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Kringas	Kringas	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
acyclovir	acyclovir	NN	B-NP	O
,	,	,	O	O
Anusol	Anusol	NN	B-NP	O
,	,	,	O	O
Bactroban	Bactroban	NN	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Mepron	Mepron	NNP	B-NP	O
750	750	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Celexa	Celexa	NN	B-NP	O
,	,	,	O	O
sirolimus	sirolimus	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Caltrate	Caltrate	NN	B-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Nexium	Nexium	NN	B-NP	O
,	,	,	O	O
tacrolimus	tacrolimus	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
lotion	lotion	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
skin	skin	NN	I-NP	O
GVHD	GVHD	NN	I-NP	O
areas	area	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-7972916	2-7972916	CD	B-NP	O
EMS	EMS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ALTO	ALTO	NN	B-NP	O
,	,	,	O	O
GARLAND	GARLAND	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NEVERSON	NEVERSON	NNP	B-NP	O
,	,	,	O	O
JAMAL	JAMAL	NNP	B-NP	O
MARION	MARION	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5901421	5901421	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/29/05	8/29/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/29/05	8/29/05	CD	B-NP	O

